NEW YORK (GenomeWeb) — Luminex reported after the close of the market Monday a 12 percent spike in third quarter revenues driven primarily by growth in assay sales across all major product categories.

NEW YORK (GenomeWeb News) – A federal court has dismissed claims against Luminex that had alleged patent infringement.

NEW YORK (GenomeWeb News) – Combinatorial chemistry systems firm Irori Technologies is suing Luminex accusing the Austin, Texas-based firm of infringing three patents with its xMAP and xTAG technologies.

This article was originally posted on Sept. 12.
Luminex has no plans to acquire any new businesses or companies at this time, its CEO Patrick Balthrop said at an investment conference last week.

Luminex's recent decision to reduce its workforce by 5 percent, close an office in Australia, and seek a buyer for its newborn screening business, was in part influenced by its attempt to obtain US regulatory clearance for its NeoPlex4 test, according to the firm's CEO.

Natural Molecular Testing created a stir in the marketplace last week when it announced it would be converting its pharmacogenetic test services to a new panel based on Luminex's xMAP multiplex bead array technology.

Natural Molecular Launches Personalized Rx Cardiac Test on Luminex xMAP

The story has been updated to include comments from GenMark.

NEW YORK (GenomeWeb News) – Luminex and Natural Molecular Testing have entered into a multiyear collaboration and licensing deal, resulting in a comprehensive personalized medicine panel.

Luminex is developing an automated, handheld, battery-powered diagnostic system based on its xMAP technology to administer both molecular and immunoassays to help diagnose soldiers or provide biosurveillance data at the point of need, the company said this week.


The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.